This inventor holds 3 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Glaxo Group Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,170 
1 out of 242 
Years Active: 2008-2014
Title: John Edward Robinson: Innovator in Pharmaceutical Chemistry
Introduction
John Edward Robinson is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Robinson's work focuses on inhibitors that target specific biological pathways.
Latest Patents
Robinson's latest patents include innovative compounds that serve as inhibitors of PI3-kinase activity. The first patent, titled "Benzpyrazol derivatives as inhibitors of PI3 kinases," is directed towards certain novel compounds of formula (I) and their salts. These compounds are designed to inhibit PI3-kinase activity, which plays a crucial role in various cellular processes. Another significant patent is "Quinoline derivatives as phosphodiesterase inhibitors," which presents novel compounds of formula (I) or pharmaceutically acceptable salts. This invention includes processes for preparing these compounds, formulations containing them, and their therapeutic use in treating inflammatory diseases.
Career Highlights
Throughout his career, Robinson has worked with prominent companies in the pharmaceutical industry. He has been associated with Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited, where he has contributed to various research and development projects. His expertise in pharmaceutical chemistry has allowed him to make impactful advancements in drug development.
Collaborations
Robinson has collaborated with several professionals in his field, including Julie Nicole Hamblin and Ian Robert Baldwin. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
John Edward Robinson is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His patents reflect his commitment to innovation and the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile